This brand name is authorized in Australia, Canada, Hong Kong, Japan, United States
The drug PREZCOBIX contains a combination of these active pharmaceutical ingredients (APIs):
1
Darunavir
UNII 33O78XF0BW - DARUNAVIR ETHANOLATE
|
Darunavir is an inhibitor of the dimerisation and of the catalytic activity of the HIV-1 protease (KD of 4.5 × 10-12 M). It selectively inhibits the cleavage of HIV encoded Gag-Pol polyproteins in virus infected cells, thereby preventing the formation of mature infectious virus particles. |
2
Cobicistat
UNII LW2E03M5PG - COBICISTAT
|
Cobicistat is a mechanism-based inhibitor of cytochromes P450 of the CYP3A subfamily. Inhibition of CYP3A-mediated metabolism by cobicistat enhances the systemic exposure of CYP3A substrates, such as darunavir, where bioavailability is limited and half-life is shortened due to CYP3A-dependent metabolism. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
PREZCOBIX Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
J05AR14 | Darunavir and cobicistat | J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AR Antivirals for treatment of HIV infections, combinations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 10903W |
Country: CA | Health Products and Food Branch | Identifier(s): 02426501 |
Country: HK | Department of Health Drug Office | Identifier(s): 64960 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 6250110F1028 |
Country: US | FDA, National Drug Code | Identifier(s): 59676-575 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.